Niels C. Riedemann

CEO & Founder at InflaRx

Prof. Riedemann received his medical training at Freiburg, Germany, and Stanford University, USA. He performed basic science research at The University of Michigan in the field of complement immunology and inflammation for several years and then completed his board certification in General Surgery at Hannover Medical School, where he still holds a Professorship in Experimental Surgery. He specialized as an Intensive Care Physician and was appointed Vice Director of Intensive Care Medicine at the Friedrich Schiller University in Jena, Germany. His research has been awarded with several national and international awards, including the Hugo-Schottmüller-Award and Hans-Liniger-Award. He has received extensive extra-mural funding and published over 50 high impact scientific publications. He serves as a member on two Boards of Directors of large scientific governmental programs. As Founder of InflaRx, Prof. Riedemann combines in-depth basic science experience and advanced clinical knowledge in the field of inflammation and acute care. Prof. Riedemann has lead InflaRx as CEO since 2007.

Location

Jena, Germany

Links


Org chart


Teams


Offices


InflaRx

InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.


Industries

Headquarters

Jena, Germany

Employees

11-50

Links